Cannabis stocks exploded higher at the start of the year and have now given up their gains. Tilray (TLRY), for instance, started the year under $10, spiked to $60, and has now lost most of its value to trade at $15.
One trader sees a rebound ahead. Over 2,970 contracts traded on the August $30 calls, a 21-fold rise in volume from the prior open interest of 141.
The buyer paid about $0.58 for the options, which will require shares to about double for them to move in-the-money.
- 25-Year-Old Prodigy Reveals Secret to Soaring Stocks
“Old school” folks might be skeptical of listening to financial advice from someone
half their age, but this stock whiz beat out 15,000 experts to claim #1 title.
It’s not out of the realm of possibility. The past few weeks have seen a surge in state looking to legalize medical or recreational cannabis. And a law that could make it easier to cannabis companies to operate in the US has been introduced in Congress.
Action to take: This is an inexpensive option with a lot of potential upside and no downside. In recent sessions, shares of Tilray have also touched on their 200-day moving average without moving meaningfully lower.
So even on a bounce higher in the next few weeks, traders could be looking at triple-digit moves here. A move to $30 is one doubling for the company, a far cry from its peak near $60.
Disclosure: The author of this article has no positions in the stock mentioned here, and does not intend to make a trade on this company after the next 72 hours. The author receives no compensation from any of the companies mentioned in this article.